Description
Description:
Rofuclav 250 mg + 62.5 mg is an antibiotic combination tablet manufactured by Radiant Pharmaceuticals Ltd., designed to treat a wide range of bacterial infections. It contains two active ingredients:
-
Cefuroxime (250 mg): A second-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis, leading to bacterial cell death.
-
Clavulanic Acid (62.5 mg): A beta-lactamase inhibitor that protects cefuroxime from degradation by beta-lactamase-producing bacteria, thereby enhancing its efficacy.
 25MG.jpeg)
 ..jpeg)
 1GM.jpeg)
 2GM.jpeg)
 20MG.jpeg)
.jpeg)
 10MG.jpeg)
 ..jpeg)
60 MG.jpeg)
Change Language